The Nano Flow Cytometry (nFCM) Market was valued at USD 0.5 billion in 2024 and is projected to reach USD 1.2 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several key factors, including the increasing demand for advanced diagnostic tools in healthcare, the rise of personalized medicine, and the growing prevalence of chronic diseases. The nFCM technology,...